Ainos Inc
NASDAQ:AIMD

Watchlist Manager
Ainos Inc Logo
Ainos Inc
NASDAQ:AIMD
Watchlist
Price: 1.85 USD -1.6% Market Closed
Market Cap: 8.9m USD

Net Margin

-13 236%
Current
Improving
by 4 090.7%
vs 3-y average of -17 326.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-13 236%
=
Net Income
$-15m
/
Revenue
$113k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-13 236%
=
Net Income
$-15m
/
Revenue
$113k

Peer Comparison

Country Company Market Cap Net
Margin
US
Ainos Inc
NASDAQ:AIMD
8.9m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.8B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.2B USD
Loading...
No Stocks Found

Market Distribution

Lower than 96% of companies in the United States of America
Percentile
4rd
Based on 15 072 companies
4rd percentile
-13 236%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Ainos Inc
Glance View

Market Cap
8.9m USD
Industry
Biotechnology

Ainos, Inc. engages in the discovery and development of pharmaceutical and biotech products. The company is headquartered in San Diego, California and currently employs 34 full-time employees. The firm is researching for the treatment of human disease indications, including Sjogren’s syndrome, thrombocytopenia, and other indications using interferon-alpha. The firm is also developing and manufacturing point-of-care testing rapid test kit products that include diagnostics for COVID-19, pneumonia, vaginal infection and helicobacter pylori bacterial infection. Its business units include Pharmaceutical, Medical Devices and Preventive Medicine Divisions. Pharmaceutical Division is focused on low-dose, orally administered lozenges containing the natural immune system activator interferon-alpha as a treatment for a variety of disease indications. Medical Device Division is developing an insulin pump and further development of point-of-care rapid test kits for the detection and diagnosis of human infections. Preventative Medicine Division is focused on SRNA-based therapeutics.

AIMD Intrinsic Value
0.2 USD
Overvaluation 89%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-13 236%
=
Net Income
$-15m
/
Revenue
$113k
What is Ainos Inc's current Net Margin?

The current Net Margin for Ainos Inc is -13 236%, which is above its 3-year median of -17 326.7%.

How has Net Margin changed over time?

Over the last 3 years, Ainos Inc’s Net Margin has decreased from -528.2% to -13 236%. During this period, it reached a low of -71 802.9% on Dec 31, 2024 and a high of -398% on Dec 31, 2022.

Back to Top